<DOC>
	<DOCNO>NCT00977925</DOCNO>
	<brief_summary>The objective study evaluate safety hemostatic effectiveness Fibrin Pad ( FP ) versus standard care treatment ( SoC ) control challenge severe soft tissue bleed abdominal , pelvic , retroperitoneal , ( non-cardiac ) thoracic surgery .</brief_summary>
	<brief_title>The Severe Soft Tissue Bleeding Study</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>Subjects &gt; = 18 year age , require elective , open , abdominal , retroperitoneal , pelvic thoracic ( noncardiac ) surgical procedure ; Presence appropriate severe bleed soft tissue Target Bleeding Site ( TBS ) identify intraoperatively surgeon ; Subjects must willing participate study , provide write informed consent . Subjects intraoperative finding identify surgeon may preclude conduct study procedure ; Bleeding site large defect artery vein injure vascular wall require repair maintenance vessel patency would result persistent exposure FP blood flow pressure heal absorption product ; Subject TBS within actively infected field ; Bleeding site , around , proximity foramen bone , area bony confine ; Subjects know intolerance blood product one component study product ; Subjects unwilling receive blood product ; Subjects know immunodeficiency disease ( include know HIV ) ; Subjects know , current alcohol / drug abuser ; Subjects participate another investigational drug device research study within 30 day enrollment ; Female subject pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Hemostasis</keyword>
</DOC>